EcoDrugPlus

Melatonin Receptor 1a

Ensembl ID : ENSMAUG00000016269
Gene Symbol: MTNR1A
1 Cross references
205 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSMAUG00000005415
Gene Symbol: MME
4 Cross references
236 Possible Orthologues:

Membrane Primary Amine Oxidase

Ensembl ID : ENSMAUG00000010190
Gene Symbol: LOC101827582
4 Cross references
321 Possible Orthologues:

Microtubule Associated Protein Tau

Ensembl ID : ENSMAUG00000021002
Gene Symbol: MAPT
2 Cross references
255 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSMAUG00000017100
Gene Symbol: MAPK1
4 Cross references
213 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSMAUG00000017023
Gene Symbol: MAPK10
1 Cross references
147 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSMAUG00000022264
Gene Symbol: MAPK11
1 Cross references
200 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSMAUG00000015940
Gene Symbol: MAPK14
4 Cross references
281 Possible Orthologues:

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSMAUG00000012073
Gene Symbol: MAPK3
1 Cross references
198 Possible Orthologues:

Mitogen-Activated Protein Kinase 8

Ensembl ID : ENSMAUG00000006379
Gene Symbol: MAPK8
4 Cross references
294 Possible Orthologues:

Mitogen-Activated Protein Kinase 9

Ensembl ID : ENSMAUG00000017175
Gene Symbol: MAPK9
4 Cross references
221 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase 1

Ensembl ID : ENSMAUG00000011379
Gene Symbol: MAP2K1
4 Cross references
209 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).